|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 4550 Montgomery Avenue |
Address2 | Suite 1100N |
| City | Bethesda |
State | MD |
Zip Code | 20814 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 60195-12
|
||||||||
|
6. House ID# 353460000
|
||||||||
| TYPE OF REPORT | 8. Year | 2025 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Joel Aurora, Attorney & Agent |
Date | 7/21/2025 6:29:18 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS
H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS
H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS
H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS
H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS
S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS
S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS
S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS
S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS
S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS
S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS
(DRAFT) PASTEUR ACT; ALL PROVISIONS
(DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS
(DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS
GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS
GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS
GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES
GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM
GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS
GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS
GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES
GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
COMMENTS IN RESPONSE TO DRAFT RULE ON PATIENT PROTECTION AND AFFORDABLE CARE ACT; MARKETPLACE INTEGRITY AND AFFORDABILITY PROPOSED RULE
LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Social Security Administration (SSA), Office of Personnel Management (OPM), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
MARY |
DWIGHT |
|
|
|
DAVID |
ELIN |
|
|
|
CASSIDY |
PELKEY |
|
|
|
ASHLEIGH |
THARP |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS
H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS
H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS
H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS
S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS
S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS
S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS
S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS
S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS
(DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS
(DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS
GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS
GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES
GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM
GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS
GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS
GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES
GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
COMMENTS IN RESPONSE TO DRAFT RULE ON PATIENT PROTECTION AND AFFORDABLE CARE ACT; MARKETPLACE INTEGRITY AND AFFORDABILITY PROPOSED RULE
LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Social Security Administration (SSA), Office of Personnel Management (OPM), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
DAVID |
ELIN |
|
|
|
MARY |
DWIGHT |
|
|
|
ASHLEIGH |
THARP |
|
|
|
CASSIDY |
PELKEY |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS
GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES
GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
DAVID |
ELIN |
|
|
|
ASHLEIGH |
THARP |
|
|
|
MARY |
DWIGHT |
|
|
|
CASSIDY |
PELKEY |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS
H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS
(DRAFT) PASTEUR ACT; ALL PROVISIONS
GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS
GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES
GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Social Security Administration (SSA), Office of Personnel Management (OPM), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
MARY |
DWIGHT |
|
|
|
DAVID |
ELIN |
|
|
|
CASSIDY |
PELKEY |
|
|
|
ASHLEIGH |
THARP |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS
H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS
S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS
S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS
GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS
GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM
GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES
GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Social Security Administration (SSA), Office of Personnel Management (OPM), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
DAVID |
ELIN |
|
|
|
MARY |
DWIGHT |
|
|
|
ASHLEIGH |
THARP |
|
|
|
CASSIDY |
PELKEY |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
H.R. 142: REGULATIONS FROM THE EXECUTIVE IN NEED OF SCRUTINY (REINS) ACT OF 2025; ALL PROVISIONS
S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS
LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Social Security Administration (SSA), Office of Personnel Management (OPM), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
MARY |
DWIGHT |
|
|
|
DAVID |
ELIN |
|
|
|
ASHLEIGH |
THARP |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |